Hypokalemia Management in Patients on Loop Diuretics

Introduction to Hypokalemia

• The American Heart Association recommends avoiding potassium supplements in patients with severe renal impairment (eGFR <30 mL/min) 1
• The European Society of Cardiology suggests using potassium supplements with caution if the patient is on ACE inhibitors or ARBs due to increased risk of hyperkalemia 2

Diagnosis and Monitoring

• The American College of Cardiology states that overlooking concomitant hypomagnesemia can make potassium repletion more difficult, as it often coexists with hypokalemia 4
• The American Heart Association recommends oral replacement as the preferred method for non-emergency hypokalemia, reserving IV potassium for severe hypokalemia (<2.5 mEq/L) or symptomatic patients 5

Treatment and Prevention

• The European Society of Cardiology recommends that potassium-sparing diuretics (spironolactone, triamterene, amiloride) should not be used as first-line therapy for hypokalemia correction in patients on loop diuretics 2
• The American College of Cardiology suggests that patients on chronic diuretic therapy should have regular potassium checks (every 1-3 months) to prevent hypokalemia 3